Evidence for the Biosynthesis of Bryostatins by the Bacterial Symbiont "Candidatus Endobugula sertula" of the Bryozoan Bugula neritina

Applied and Environmental Microbiology

Volumn 67, Issue 10, 2001, Pages 4531-4537

  Davidson, S K ^a,b,d   Allen, S W ^c,e   Lim, G E ^a,b   Anderson, C M ^a,b   Haygood, M G ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CalBioMarine Technologies Inc   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Puracyp LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN 1; LACTONE; MACROLIDE; MULTIENZYME COMPLEX;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BRYOZOA; DNA SEQUENCE; ENZYMOLOGY; GAMMAPROTEOBACTERIA; GENETICS; GROWTH, DEVELOPMENT AND AGING; IN SITU HYBRIDIZATION; METABOLISM; MICROBIOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; SYMBIOSIS;

AMINO ACID SEQUENCE; ANIMALS; BRYOZOA; CLONING, MOLECULAR; GAMMAPROTEOBACTERIA; IN SITU HYBRIDIZATION; LACTONES; MACROLIDES; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; SEQUENCE ANALYSIS, DNA; SYMBIOSIS;

EID: 0035487279     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.67.10.4531-4537.2001     Document Type: Article

References (34)

1. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
2. Anthoni, U., P. H. Nielsen, M. Perieira, and C. Christophersen. 1990. Comp. Biochem. Physiol. 96B:431-437.
3. Baldwin, N. G., C. D. Rice, T. M. Tuttle, H. D. Bear, J. I. Hirsch, and R. E. Merchant. 1997. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes. J. Neurooncol. 32:19-28.
4. Basu, A. 1998. The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha. Mol. Pharmacol. 53: 105-111.
5. Correale, P., M. Caraglia, A. Fabbrocini, R. Guarrasi, S. Pepe, V. Patella, G. Marone, A. Pinto, A. R. Bianco, and P. Tagliaferri. 1995. Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the beta 1 integrin profile of cultured human tumor cells. Anticancer Drugs 6:285-90.
6. Davidson, S. K. 1999. The biology of the bryostatins in the marine bryozoan Bugula neritina. Dissertation. University of California, San Diego, La Jolla, Calif.
7. Davidson, S. K., and M. G. Haygood. 1999. Identification of sibling species of the bryozoan Bugula neritina that produce different anticancer bryostatins and harbor distinct strains of the bacterial symbiont "Candidatus Endobugula sertula." Biol. Bull. 196:273-280.
8. DeLong, E. F., L. T. Taylor, T. L. Marsh, and C. M. Preston. 1999. Visualization and enumeration of marine planktonic archaea and bacteria by using polyribonucleotide probes and fluorescent in situ hybridization. Appl. Environ. Microbiol. 65:5554-5563.
9. DeVries, D. J., C. L. Herald, G. R. Pettit, and P. M. Blumberg. 1988. Demonstration of sub-nanomolar affinity of bryostatin 1 for the phorbol ester receptor in rat brain. Biochem. Pharmacol. 37:4068-4073.
10. DeVries, D. J., K. S. Rao, and R. H. Willis. 1997. Application of a radioreceptor assay to the screening and characterisation of compounds from marine organisms with activity at the phorbol ester binding site of protein kinase C. Toxicon 35:347-354.
11. Ferris, M. J., G. Muyzer, and D. M. Ward. 1996. Denaturing gradient gel electrophoresis profiles of 16S rRNA-defined populations inhabiting a hot spring microbial mat community. Appl. Environ. Microbiol. 62:340-346.
12. Fleming, M. D., H. D. Bear, K. Lipshy, P. J. Kostuchenko, D. Portocarero, A. W. McFadden, and S. K. Barrett. 1995. Adoptive transfer of bryostatin-activated tumor-sensitized lymphocytes prevents or destroys tumor metastases without expansion in vitro. J. Immunother. Emphasis Tumor Immunol. 18:147-55.
13. Grant, S., R. Traylor, G. R. Pettit, and P. S. Lin. 1994. The macrocyclic lactone protein kinase C activator, bryostatin 1, either alone, or in conjunction with recombinant murine granulocyte-macrophage colony-stimulating factor, protects Balb/c and C3H/HeN mice from the lethal in vivo effects of ionizing radiation. Blood 83:663-667.
14. Haygood, M., D. Distel, and P. Herring. 1992. Polymerase chain reaction and 16S rRNA gene sequences from the luminous bacterial symbionts of two deep-sea anglerfishes. J. Mar. Biol. Assoc. U. K. 71:149-159.
15. Haygood, M. G., and S. K. Davidson. 1997. Small subunit ribosomal RNA genes and in situ hybridization of the bacterial symbionts in the larvae of the bryozoan Bugula nertina and proposal of "Candidatus Endobugula sertula." Appl. Env. Microbiol. 63:4612-4616.
16. Johnson, M. D., J. A. Torri, M. E. Lippman, and R. B. Dickson. 1999. Regulation of motility and protease expression in PKC-mcdiated induction of MCF-7 breast cancer cell invasiveness. Exp. Cell Res. 247:105-113.
17. Keough, M. J. 1989. Dispersal of the bryozoan Bugula neritina and effects of adults on newly metamorphosed juveniles. Mar. Ecol. Prog. Ser. 57:163-171.
18. Kraft, A. S., J. B. Smith, and R. L. Berkow. 1986. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc. Natl. Acad. Sci. USA 83:1334-1338.
19. Kraft, A. S., S. Woodley, G. R. Pettit, F. Gao, J. C. Coll, and F. Wagner. 1996. Comparison of the antitumor activity of bryostatins 1, 5, and 8. Cancer Chemother. Pharmacol. 37:271-278.
20. Lind, D. S., T. M. Tuttle, K. P. Bethke, J. L. Frank, C. W. McCrady, and H. D. Bear. 1993. Expansion and tumor specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients. Surg. Oncol. 2:273-282.
21. Lipshy, K. A., P. J. Kostuchenko, G. G. Hamad, C. E. Bland, S. K. Barrett, and H. D. Bear. 1997. Sensitizing T-lymphocytcs for adoptive immunotherapy by vaccination with wild-type or cytokine gene-transduced melanoma. Ann. Surg. Oncol. 4:334-341.
22. Maloy, S. R., V. J. Stewart, and R. K. Taylor. 1996. Genetic analysis of pathogenic bacteria. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
23. Muyzer, G., E. C. D. Waal, and A. G. Uitterlinden. 1993. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 59:695-7011.
24. Pettit, G. R., C. L. Herald, D. L. Doubek, and D. L. Herald. 1982. Isolation and structure of bryostatin 1. J. Am. Chem. Soc. 104:6846-6848.
25. Pettit, G. R. 1991. The bryostatins. Prog. Chem. Org. Nat. Prod. 57:153-195.
26. Pluda, J. M., B. D. Cheson, and P. H. Phillips. 1996. Clinical trials referral resource. Clinical trials using bryostatin-1. Oncology (Huntington) 10:740-742.
27. Schaufelberger, D. E., A. B. Alvarado, P. Andrews, and J. A. Beutler. 1990. Detection and quantitation of bryostatin 1 and 2 in Bugula neritina by combined high-performance liquid chromatography and 3H-phorbol dibutyrate displacement. J. Liq. Chromatography 13:583-598.
28. Scheid, C., J. Prendiville, G. Jayson, D. Crowther, B. Fox, G. R. Pettit, and P. L. Stern. 1994. Immunomodulation in patients receiving intravenous bryostatin 1 in a phase I clinical study: comparison with effects of bryostatin 1 on lymphocyte function in vitro. Cancer Immunol. Immunother. 39:223-230.
29. Shure, M., S. Wessler, and N. Fedoroff. 1983. Molecular identification and isolation of the waxy locus in maize. Cell 35:225-233.
30. Smith, J. B., L. Smith, and G. R. Pettit. 1985. Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters. Biochem. Biophys. Res. Commun. 132:939-945.
31. Steube, K. G., and H. G. Drexler. 1993. Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1. Leuk. Lymphoma 9:141-148.
32. Sung, S. J., P. S. Lin, R. Schmidt-Ullrich, C. E. Hall, J. A. Walters, C. McCrady, and S. Grant. 1994. Effects of the protein kinase C stimulant bryostatin 1 on the proliferation and colony formation of irradiated human T-lymphocytes. Int. J. Radiat. Biol. 66:775-783.
33. Taylor, L. S., G. W. Cox, G. Melillo, M. C. Bosco, and I. Espinoza-Delgado. 1997. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages. Cancer Res. 57:2468-73.
34. Woollacott, R. M. 1981. Association of bacteria with bryozoans larvae. Mar. Biol. 65:155-158.